Zosano Pharma Corporation (NASDAQ:ZSAN) reports Quarterly Earnings: Stock Surges 30% in a Week

March 28, 2022

Clinical stage biopharmaceutical firm Zosano Pharma Corporation (NASDAQ:ZSAN) saw its stock make a big move over the course of the past week as it clocked gains of as much as 30% during the period. While the gains made by the stock were considerable, it ought to be noted that there was no news about the company last week. Trading Data On Friday, ZSAN stock fell 8.16% to $0.2320 with more…

Read More >>

Zosano Pharma Corp (NASDAQ:ZSAN) Stock Slumps As Investors Panicked On Stock Offerings

February 10, 2022

Zosano Pharma Corp (NASDAQ: ZSAN) fell 48% in the previous session as investors responded negatively to the company announcing pricing of an underwritten public offering of 51.25 million units, each comprising a common share and one warrant to buy one common share at a $0.3 public offering price per unit. Trading Data On Wednesday, ZSAN stock slumped 48.56% to $0.2431 with more than 98.02 million shares, compared to its average…

Read More >>